ArticleJournal of cell science2026
Glucocorticoids regulate small extracellular vesicle release via activation of nSMase2.
Article in Journal of cell science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Small vesicles, big potential: A review of innovative exosome delivery and molecular mechanisms in preclinical myocardial infarction models.Animal models and experimental medicine · 2026Review
- Sleep and stress as modifiable drivers of Alzheimer's disease.NPJ dementia · 2026Review
Corrections and comments
- Update of
Authors and funding
2 authors.
Funding
Abstract
Glucocorticoid (GC) steroid hormones mediate the stress response, which requires dynamic communication between brain regions to enable an organism to react to and overcome perceived stressors. While many effects of GCs on the brain have been well-studied, little is known about whether and how GCs regulate brain cell-cell communication through the release of small extracellular vesicles (sEVs), nanoparticles that carry bioactive molecules between cells. Here, we use total internal reflection fluorescence (TIRF) microscopy and the pH-sensitive sEV marker mCh-CD63-pHluorin to visualize sEV release in a neuronal cell line. We find that GCs stimulate sEV secretion and that this process requires the GTPase Rab27a and the enzyme neutral sphingomyelinase 2 (nSMase2), which catalyzes ceramide production and drives sEV formation. We further show that GCs promote sEV release by activating nSMase2 downstream of mitochondrial reactive oxygen species production and opening of the mitochondrial permeability transition pore (mPTP). These findings link GC impacts on mitochondria, specifically via mPTP opening, to nSMase2 activation and enhanced sEV release by neuronal cells.
Indexed as
Identifiers
42059363What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.